These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 33824127)
41. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Kumar Y; Singh H; Patel CN J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274 [TBL] [Abstract][Full Text] [Related]
42. Structure-guided pharmacophore based virtual screening, docking, and molecular dynamics to discover repurposed drugs as novel inhibitors against endoribonuclease Nsp15 of SARS-CoV-2. Jha P; Saluja D; Chopra M J Biomol Struct Dyn; 2023 Jul; 41(11):5096-5106. PubMed ID: 35652904 [TBL] [Abstract][Full Text] [Related]
44. Potential inhibitors for the novel coronavirus (SARS-CoV-2). Han Y; Wang Z; Ren J; Wei Z; Li J Brief Bioinform; 2021 Mar; 22(2):1225-1231. PubMed ID: 32942296 [TBL] [Abstract][Full Text] [Related]
45. Analysis of natural compounds against the activity of SARS-CoV-2 NSP15 protein towards an effective treatment against COVID-19: a theoretical and computational biology approach. Motwalli O; Alazmi M J Mol Model; 2021 May; 27(6):160. PubMed ID: 33963942 [TBL] [Abstract][Full Text] [Related]
46. SARS-CoV-2 nsp15 preferentially degrades AU-rich dsRNA via its dsRNA nickase activity. Wang X; Zhu B Nucleic Acids Res; 2024 May; 52(9):5257-5272. PubMed ID: 38634805 [TBL] [Abstract][Full Text] [Related]
47. An atomistic model of the coronavirus replication-transcription complex as a hexamer assembled around nsp15. Perry JK; Appleby TC; Bilello JP; Feng JY; Schmitz U; Campbell EA J Biol Chem; 2021 Oct; 297(4):101218. PubMed ID: 34562452 [TBL] [Abstract][Full Text] [Related]
48. Atovaquone and Pibrentasvir Inhibit the SARS-CoV-2 Endoribonuclease and Restrict Infection In Vitro but Not In Vivo. von Beck T; Mena Hernandez L; Zhou H; Floyd K; Suthar MS; Skolnick J; Jacob J Viruses; 2023 Aug; 15(9):. PubMed ID: 37766247 [TBL] [Abstract][Full Text] [Related]
50. Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes. Qayyum S; Mohammad T; Slominski RM; Hassan MI; Tuckey RC; Raman C; Slominski AT Am J Physiol Endocrinol Metab; 2021 Aug; 321(2):E246-E251. PubMed ID: 34181461 [TBL] [Abstract][Full Text] [Related]
51. Targeting SARS-CoV-2 endoribonuclease: a structure-based virtual screening supported by in vitro analysis. Ibrahim IM; Elfiky AA; Fathy MM; Mahmoud SH; ElHefnawi M Sci Rep; 2022 Aug; 12(1):13337. PubMed ID: 35922447 [TBL] [Abstract][Full Text] [Related]
52. New antiviral target revealed by the hexameric structure of mouse hepatitis virus nonstructural protein nsp15. Xu X; Zhai Y; Sun F; Lou Z; Su D; Xu Y; Zhang R; Joachimiak A; Zhang XC; Bartlam M; Rao Z J Virol; 2006 Aug; 80(16):7909-17. PubMed ID: 16873248 [TBL] [Abstract][Full Text] [Related]
53. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening. Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740 [TBL] [Abstract][Full Text] [Related]
54. The severe acute respiratory syndrome coronavirus Nsp15 protein is an endoribonuclease that prefers manganese as a cofactor. Bhardwaj K; Guarino L; Kao CC J Virol; 2004 Nov; 78(22):12218-24. PubMed ID: 15507608 [TBL] [Abstract][Full Text] [Related]
55. Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics. Pillon MC; Frazier MN; Dillard LB; Williams JG; Kocaman S; Krahn JM; Perera L; Hayne CK; Gordon J; Stewart ZD; Sobhany M; Deterding LJ; Hsu AL; Dandey VP; Borgnia MJ; Stanley RE Nat Commun; 2021 Jan; 12(1):636. PubMed ID: 33504779 [TBL] [Abstract][Full Text] [Related]
56. Mutational analysis of the SARS virus Nsp15 endoribonuclease: identification of residues affecting hexamer formation. Guarino LA; Bhardwaj K; Dong W; Sun J; Holzenburg A; Kao C J Mol Biol; 2005 Nov; 353(5):1106-17. PubMed ID: 16216269 [TBL] [Abstract][Full Text] [Related]
57. Porcine deltacoronavirus nsp15 antagonizes interferon-β production independently of its endoribonuclease activity. Liu X; Fang P; Fang L; Hong Y; Zhu X; Wang D; Peng G; Xiao S Mol Immunol; 2019 Oct; 114():100-107. PubMed ID: 31351410 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of action of steroid molecules on SARS-CoV-2 by inhibiting NSP-15, an endoribonuclease. Dhanabalan AK; Raghavan SS; Rajendran S; Ramasamy V; Abdul SAA; Narayanasamy N; Krishnasamy G Mol Divers; 2023 Dec; 27(6):2715-2728. PubMed ID: 36456773 [TBL] [Abstract][Full Text] [Related]
59. Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations. Vardhan S; Sahoo SK J Tradit Complement Med; 2022 Jan; 12(1):44-54. PubMed ID: 34926189 [TBL] [Abstract][Full Text] [Related]
60. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease. Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]